✦ LIBER ✦

Association of Gadolinium Based Magnetic Resonance Imaging Contrast Agents and Nephrogenic Systemic Fibrosis

✍ Scribed by Bhave, Gautam; Lewis, Julia B.; Chang, Sam S.

Book ID: 122040504
Publisher: Lippincott Williams and Wilkins
Year: 2008
Tongue: English
Weight: 113 KB
Volume: 180
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2008.05.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nephrogenic Systemic Fibrosis and Gadoli

Nephrogenic Systemic Fibrosis and Gadolinium-Based Contrast Agents

✍ Abu-Alfa, Ali K. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 165 KB

Nephrogenic systemic fibrosis and the us

Nephrogenic systemic fibrosis and the use of gadolinium-based contrast agents

✍ Jeffrey G. Penfield 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 167 KB

Nephrogenic Fibrosing Dermopathy/Nephrog

Nephrogenic Fibrosing Dermopathy/Nephrogenic Systemic Fibrosis (NFD/NSF) and Gadolinium-Based Magnetic Resonance Contrast Agents (GBMCAs): A Literature Review

✍ Robb-Belville, Sonja K. 📂 Article 📅 2007 🏛 Elsevier Science ⚖ 117 KB

Gadolinium-Containing Magnetic Resonance

Gadolinium-Containing Magnetic Resonance Imaging Contrast and Nephrogenic Systemic Fibrosis: A Case-Control Study

✍ Alexander J. Kallen; Michael A. Jhung; Steven Cheng; Theresa Hess; George Turabe 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 241 KB

Strong association between the use of ga

Strong association between the use of gadolinium-based contrast agents with nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis

✍ J. Jamboti 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB

Biochemical safety profiles of gadoliniu

Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis

✍ Hale Ersoy; Frank J. Rybicki 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

## Abstract Gadolinium (Gd)‐based paramagnetic contrast agents are relatively safe when used in clinically recommended doses. However, with the rapidly expanding body of literature linking Gd‐based paramagnetic contrast agents and nephrogenic systemic fibrosis (NSF), awareness of the potential side